GOSSAMER BIO, INC. Stock Issued During Period, Shares, New Issues
GOSSAMER BIO, INC. (GOSS) reported Stock Issued During Period, Shares, New Issues of 9.43 million shares for the 0-month period ending 2020-05-21, per its 10-Q filed 2020-08-11.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2025-03-13
- 2020-05-21: Stock Issued During Period, Shares, New Issues 0 month 9.43M shares; Stock Issued During Period, Shares, New Issues 9.43M shares.
| Period end | Stock Issued During Period, Shares, New Issues 0 month | Stock Issued During Period, Shares, New Issues |
|---|---|---|
| 2020-05-21 | 9.43M shares 10-Q · filed 2020-08-11 | 9.43M shares 10-K · filed 2025-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 |